Coloplast A/S CLPBF
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.15B | 1.14B | 1.11B | 1.10B | 1.09B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.15B | 1.14B | 1.11B | 1.10B | 1.09B |
| Cost of Revenue | 396.18M | 380.82M | 370.70M | 359.74M | 344.31M |
| Gross Profit | 752.33M | 763.81M | 738.73M | 738.02M | 745.95M |
| SG&A Expenses | 428.36M | 423.77M | 417.52M | 412.11M | 394.43M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -4.47M | -3.89M | -3.60M | -935.20K | -12.53M |
| Total Operating Expenses | 863.96M | 844.43M | 824.40M | 809.41M | 765.22M |
| Operating Income | 284.55M | 300.20M | 285.03M | 288.35M | 325.04M |
| Income Before Tax | 219.88M | 291.64M | -194.82M | 279.16M | 243.58M |
| Income Tax Expenses | 37.26M | 64.12M | -42.75M | 61.41M | 106.52M |
| Earnings from Continuing Operations | 182.62M | 227.53M | -152.07M | 217.74M | 137.07M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 182.62M | 227.53M | -152.07M | 217.74M | 137.07M |
| EBIT | 284.55M | 300.20M | 285.03M | 288.35M | 325.04M |
| EBITDA | 341.83M | 356.70M | 339.69M | 342.12M | 360.64M |
| EPS Basic | 0.81 | 1.01 | -0.68 | 0.97 | 0.61 |
| Normalized Basic EPS | 0.67 | 0.82 | 0.77 | 0.79 | 0.80 |
| EPS Diluted | 0.81 | 1.01 | -0.68 | 0.97 | 0.61 |
| Normalized Diluted EPS | 0.67 | 0.82 | 0.77 | 0.79 | 0.80 |
| Average Basic Shares Outstanding | 225.40M | 225.20M | 225.20M | 225.00M | 225.40M |
| Average Diluted Shares Outstanding | 225.40M | 225.20M | 225.20M | 225.00M | 225.40M |
| Dividend Per Share | 2.77 | 0.00 | 0.78 | -- | 2.82 |
| Payout Ratio | -- | 77.02% | 0.00% | 290.41% | -- |